Broadfin Capital’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$3.57M Buy
1,888,039
+268,039
+17% +$507K 0.48% 31
2019
Q3
$1.75M Buy
+1,620,000
New +$1.75M 0.32% 36
2019
Q2
Sell
-2,030,925
Closed -$12.2M 35
2019
Q1
$12.2M Buy
2,030,925
+153,423
+8% +$919K 2.51% 13
2018
Q4
$13.9M Buy
+1,877,502
New +$13.9M 1.82% 12